Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).
Wieke W KremerStèfanie DickDaniëlle A M HeidemanRenske D M SteenbergenMaaike C G BleekerHarold R VerhoeveWilhelmina M van BaalNienke E van TrommelGemma G KenterChris J L M MeijerJohannes BerkhofPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
methylation test showed clinical regression. Methylation, in combination with cytology or HPV genotyping, can be used to support a wait-and-see policy in women with CIN2/3.